Conference
Benralizumab continues to improve quality of life after 6 months of treatment in Canadians with severe eosinophilic asthma
Authors
Penz E; Kayaniyil S; Lancaster B; Francoeur B; Lee JK; Mallet M; Tourin O; Ramesh W; Mahdavian M; Walker BL
Publisher
European Respiratory Society (ERS)
Publication Date
September 4, 2022
DOI
10.1183/13993003.congress-2022.1024
Name of conference
05.01 - Airway pharmacology and treatment